TNDM financials
Tandem Diabetes (TNDM) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
TNDM income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $1.01B | $530.85M | -$78.12M | -$204.71M | -3.04 |
| 2024 | $940.20M | $489.57M | -$99.13M | -$96.03M | -1.47 |
| 2023 | $747.72M | $367.69M | -$233.23M | -$222.61M | -3.43 |
| 2022 | $801.22M | $412.99M | -$92.85M | -$94.59M | -1.47 |
| 2021 | $702.80M | $376.21M | $22.65M | $15.57M | 0.24 |
| 2020 | $498.83M | $260.52M | -$7.96M | -$34.38M | -0.56 |
- TNDM revenue was $1.01B in fiscal 2025, net income -$204.71M.
Updated 2026-11-03 01:57 UTC